Trial Profile
Phase 2 Trial of Maximum Androgen Blockade (MAB) Dose Escalation From 50 mg to 150 mg Bicalutamide (Casodex) for Biochemical Failure in Prostate Cancer Patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms CHICS
- 13 May 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 13 May 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 13 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.